Iressa: Brand name for gefitinib, a drug that attaches to the epidermal growth factor receptor (EGFR) on the surfaces of cells . People with non-small-cell lung cancer who have a mutation in the gene for EGFR enjoy a rapid and often dramatic response to the drug. For more information, see: gefitinib (Iressa)